Sanochemia Pharmazeutika AG Ends Public Offering of Corporate Bond
Sanochemia Pharmazeutika AG has concluded the public offering of its corporate bond. Further details on the offering's outcome and the bond's terms have not yet been published.
Sanochemia Pharmazeutika AG has announced the termination of the public offering for its corporate bond. The decision to end the offering was made under specific conditions, which the company has now implemented.
According to the statement, the withdrawal or termination of the offering was permissible should the company decide to do so, and Sanochemia Pharmazeutika has made this decision. The subscription period for the bond was set to end on February 23, 2024, having originally opened on February 16, 2024.
The bond was intended to be issued with a nominal value of 10 million euros and formed part of the company's financing strategy. The company has not yet provided further details on how the cessation of the offering will affect its financial plans or future investments. The interest rate for the bond was set at 8.5 percent, with a maturity date of February 16, 2027.